Please enable JavaScript or talk to your local administrator to get JavaScript enabled.

Project

A revolutionary shape memory alloy-based disposable device for bladder cancer removal

Funder: European Commission

Funding period
EUR 50 K
USD 56 K
Funding amount
Abstract
Bladder cancer represents the 9th most common malignancy worldwide and the 4th most common in men. Globally approximately 2.5M people suffer from it, with 420,000 newly diagnosed cases each year. In Europe, a total of 118,000 new cases and 52,000 deaths are estimated annually. With population growth and ageing, the absolute incidence of bladder cancer might be further escalating.
Despite the increasing incidences, the current treatments remain ineffective. The gold standard Trans-Urethral Resection of Bladder Tumour (TURBT) has up to 61% risk of tumour recurrence due to incomplete removal or tumour cell implantation during the procedure.
CML introduces U-TURBT, an innovative disposable device for the treatment of bladder cancer. By covering and sealing the portion of bladder affected by the tumour, it avoids tumour cell spillage and dissemination. By minimising the risk of recurrence, U-TURBT improves patients’ health and quality of life, and cuts down the expenses of the healthcare providers relative to additional treatments.
During the feasibility assessment, a go-to-market strategy and a supply chain will be established, as well as further development plan will be drafted. During the second phase of innovation project, CML will upgrade the device to permit en bloc bladder tumour resection and extrication. Large scale clinical trial will then be initiated for obtaining CE mark as a medical device
Similar projects All >
Sorted by: Start Date
Project list item
Implication of neutrophil extracellular traps in the efficacy of bladder-sparing therapy in muscle invasive bladder cancer

Canadian Institutes of Health Research to Wassim Kassouf, Jonathan David Spicer, Ciriaco A. Piccirillo

USD 138,878
2020 - 2025
Project list item
CD40 agonism for the treatment of bladder cancer

National Cancer Institute to CHRISTOPHER STUART GARRIS

USD 64,554
2020 - 2023
Project list item
Roles of epigenetic regulators in bladder cancer progression

University of California - Cancer Research Coordinating Committee to Zhu Wang

USD 74,960
2020 - 2020
Project list item
Chemotherapy plus PD-1 blockade as bladder-sparing treatment for muscle-invasive bladder cancer

V Foundation for Cancer Research to Matthew D Galsky

USD 600,000
2019 - 2022
Project list item
Engineering Smart Solutions for Disorders of the Bladder Urothelium

Engineering and Physical Sciences Research Council

 
2019 - 2023

System

Categories
  • FOR (ANZSRC)

    1112 Oncology and Carcinogenesis

  • RCDC

    Cancer

  • RCDC

    Clinical Research

  • RCDC

    Clinical Trials and Supportive Activities

  • RCDC

    Urologic Diseases

  • HRCS HC

    Cancer

  • Health Research Areas

    Biomedical

  • Broad Research Areas

    Clinical Medicine and Science